Table 1 Number of included studies and enrolled patients according to the individual interventions
Interventions | Studies (n) | Patients (n) | Operation | Published year |
|---|---|---|---|---|
Ketorolac | 1 | 65 | ULS | 2014 |
Lidocaine | 1 | 66 | TURBt | 2020 |
Ketamine | 2 | 82 | TURBt | 2016 |
Parecoxib | 1 | 61 | TURBt | 2018 |
Solifenacin | 1 | 62 | TURBt | 2015 |
Magnesium | 1 | 60 | TURBt | 2020 |
Dexmedetomidine | 2 | 79 | TURBt | 2015–2016 |
Chlorpheniramine | 2 | 76 | TURBt&UL | 2021 |
Nefopam | 2 | 63 | TURBt&UL | 2018–2021 |
Penile nerve block | 2 | 126 | TURBt&TURP | 2017–2021 |
Gabapentin | 1 | 50 | PCNL | 2018 |
Tolterodine | 1 | 50 | PCNL | 2018 |
Bupivancaine | 1 | 31 | PCNL | 2020 |
Oxycodone | 1 | 46 | TURP | 2019 |
Hyoscine N-butyl bromide | 1 | 24 | TURP | 2017 |
Placebo | 18 | 875 | 2014–2021 | |
Total | 18 | 1816 | 2014–2021 |